8-K: CDT Equity Inc. Amends Loan, Increases Debt and Dilution Risk

CDT Equity Inc. has amended its loan agreement multiple times, significantly increasing its debt principal and interest rate, while also introducing potential share dilution through convertible notes and warrants.

Summary

• CDT Equity Inc. has entered into a second and third amendment to its loan agreement with J.J. Astor & Co.
• The principal amount of the senior secured convertible promissory note has been increased to $2,536,650.
• The interest rate on the note has been raised to 19%.
• Repayments will be made in twenty-three equal weekly installments starting August 19, 2026.
• The company has increased the proceeds due to the lender from its existing Sales Agreement with A.G.P./Alliance Global Partners from 80% to 90% to service the debt.
• The lender has the option to convert the outstanding balance into common stock at a reduced conversion price (70% of 20-day VWAP, previously 90% of 10-day VWAP), subject to shareholder approval.
• The company has issued warrants to purchase 37,500 shares of common stock at $7.20 per share.
• The definition of 'Floor Price' for conversion has been adjusted, with adjustments occurring every six months.
• Issuance of conversion shares and warrant shares exceeding 19.99% of outstanding shares requires stockholder approval.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative development due to increased debt, higher interest rates, and dilution concerns, despite the company's efforts to secure funding.

Positives

• Secured additional funding of $200,000 through the third amendment.
• The company is actively managing its financing needs to continue operations.

Negatives

• Significant increase in total debt principal to $2,536,650.
• Elevated interest rate of 19% on the convertible note.
• Increased reliance on sales agreement proceeds (90%) to service debt.
• Potential for substantial share dilution due to convertible note and warrants.
• Conversion price for shares has been lowered, increasing the likelihood of conversion.
• The need for shareholder approval for share issuances above 19.99% could create future hurdles.

Risks

• Risk of significant shareholder dilution if the lender converts the note or exercises warrants.
• Increased financial burden due to higher debt principal and interest rate.
• Dependence on sales agreement revenue to meet weekly debt obligations.
• Potential for further amendments or defaults if financial performance does not improve.
• The company may struggle to obtain necessary shareholder approval for future share issuances.

Future Outlook

The company must secure shareholder approval by August 28, 2026, for potential share issuances exceeding 19.99% of outstanding stock. A resale registration statement must be filed by August 31, 2026, and become effective by September 11, 2026. The 'Floor Price' definition will adjust every six months starting December 11, 2026.

Management Comments

• The company is working to meet its financial obligations through amendments to its loan agreements.
• The issuance of shares and warrants is subject to shareholder approval as required by Nasdaq rules.

Industry Context

StockSavvy.ai notes that frequent amendments to loan agreements, increasing debt, and offering convertible instruments are common strategies for early-stage or growth companies facing capital constraints. However, the high interest rate and significant dilution potential in this case are concerning indicators.

Related Party Transactions

• The loan agreement and amendments are with J.J. Astor & Co., which is identified as the Lender. The nature of the relationship beyond lender is not specified, but the terms suggest a close financial relationship.

Stakeholder Impact

• Shareholders: Potential for significant dilution of ownership stake due to conversion of debt and exercise of warrants, especially if conversion price is favorable to the lender.
• Creditors: Increased risk for other creditors due to the company's higher debt load and the senior secured nature of this note.
• Management: Increased pressure to meet debt obligations and potentially secure shareholder approval for dilutive issuances.

Next Steps

• Obtain stockholder approval for share issuances exceeding 19.99% by August 28, 2026.
• File a resale registration statement by August 31, 2026.
• Ensure the resale registration statement is effective by September 11, 2026.
• Commence weekly debt installments starting August 19, 2026.
• The 'Floor Price' definition will adjust every six months, starting December 11, 2026.

Key Dates

Recommendation

The filing indicates a worsening financial situation with increased debt, a high interest rate, and significant potential for share dilution. The company's reliance on further financing and the aggressive terms of the current debt suggest a high-risk profile, making it unfavorable for investors.

Keywords

convertible note, loan agreement amendment, debt financing, shareholder approval, warrants, dilution, Nasdaq, promissory note